TotalMarketCap

BridgeBio Oncology Therapeutics

BBOTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$175.181 M

$2.19 -5.00%

Close of 6 Nov 2026

As of 6 Nov 2026, BridgeBio Oncology Therapeutics (BBOT) has a market capitalization of $175.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$134.0M

Loss-making

Shares outstanding

80,174,267

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #254Natures Sunshine ProductsNATR$176.6M
  2. #255Upstream BioUPB$175.8M
  3. #256BridgeBio Oncology TherapeuticsBBOT$175.2M
  4. #257Whitehawk TherapeuticsWHWK$173.9M
  5. #258Zentalis PharmaceuticalsZNTL$162.8M

What if BridgeBio Oncology Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$352,193.73

Per share 161,187× higher

Bitcoin $1.53T

$19,056.59

Per share 8,722× higher

Apple $5.02T

$62,561.00

Per share 28,632× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for BridgeBio Oncology Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.